(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are ADOCIA, COFACE, and RANA GRUBER.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| ADOCIA (ADOC.PA) | 4.11 | 13.4% | 2023-05-26 11:35:40 |
| COFACE (COFA.PA) | 13.31 | 9.73% | 2023-05-26 11:46:40 |
| RANA GRUBER (RANA.OL) | 55.10 | 7.41% | 2023-05-26 11:32:50 |
| SAS AB (SASNO.OL) | 0.35 | 6.75% | 2023-05-26 11:33:09 |
| CRCAM LANGUED CCI (CRLA.PA) | 52.50 | 6.01% | 2023-05-26 11:47:13 |
| FAURECIA (EO.PA) | 20.75 | 5.44% | 2023-05-26 11:49:18 |
| POLIGHT (PLT.OL) | 11.42 | 5.35% | 2023-05-26 11:32:40 |
| ATOS (ATO.PA) | 13.80 | 4.62% | 2023-05-26 11:36:58 |
| ARAMIS GROUP (ARAMI.PA) | 5.09 | 3.67% | 2023-05-26 11:36:39 |
| COHERIS (COH.PA) | 4.20 | 3.45% | 2023-05-26 11:46:52 |
The three biggest losers today are CASINO GUICHARD, ABIONYX PHARMA, and BARBARA BUI.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CASINO GUICHARD (CO.PA) | 6.08 | -10.06% | 2023-05-26 11:45:59 |
| ABIONYX PHARMA (ABNX.PA) | 1.26 | -8.59% | 2023-05-26 11:35:19 |
| BARBARA BUI (BUI.PA) | 9.00 | -8.16% | 2023-05-26 11:45:11 |
| GENSIGHT BIOLOGICS (SIGHT.PA) | 0.75 | -7.84% | 2023-05-26 11:50:41 |
| BIGBEN INTERACTIVE (BIG.PA) | 5.23 | -4.91% | 2023-05-26 11:45:24 |
| PCI BIOTECH HOLD (PCIB.OL) | 1.80 | -4.66% | 2023-05-26 11:32:26 |
| OCEANTEAM (OTS.OL) | 1.46 | -4.58% | 2023-05-26 11:32:01 |
| LERØY SEAFOOD GP (LSG.OL) | 49.38 | -4.49% | 2023-05-26 11:31:08 |
| GRIEG SEAFOOD (GSF.OL) | 85.90 | -4.24% | 2023-05-26 11:30:19 |
| SALMAR (SALM.OL) | 496.90 | -4.07% | 2023-05-26 11:33:01 |
Winners today
1. ADOCIA (ADOC.PA)
13.4% Price Change
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
CAC 40 ended the session with ADOCIA jumping 13.4% to €4.11 on Friday while CAC 40 jumped 1.24% to €7,319.18.
Earnings Per Share
As for profitability, ADOCIA has a trailing twelve months EPS of €-0.96.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADOCIA’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
ADOCIA’s stock is valued at €4.11 at 22:40 EST, way under its 52-week high of €6.46 and way higher than its 52-week low of €2.80.
Revenue Growth
Year-on-year quarterly revenue growth grew by 312.1%, now sitting on 13.95M for the twelve trailing months.
Moving Average
ADOCIA’s worth is way higher than its 50-day moving average of €3.58 and higher than its 200-day moving average of €3.96.
More news about ADOCIA.
2. COFACE (COFA.PA)
9.73% Price Change
COFACE SA, through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners. The company offers credit insurance products to protect companies against default on payment of its trade receivables. It also provides integrated credit management solutions comprising credit insurance, single risk insurance, business information and debt collection services for insured and uninsured businesses; and factoring services, as well as contract and environmental surety, customs and excise, and legal bonds; and payment guarantees. In addition, the company offers business information services through its ICON portal, an information services web platform. It operates in Western Europe, Northern Europe, Central and Eastern Europe, the Mediterranean and Africa, North America, Latin America, and the Asia-Pacific. COFACE SA was founded in 1946 and is headquartered in Bois-Colombes, France.
CAC 40 ended the session with COFACE jumping 9.73% to €13.31 on Friday, after four sequential sessions in a row of losses. CAC 40 rose 1.24% to €7,319.18, after four consecutive sessions in a row of losses, on what was an all-around bullish trend exchanging session today.
Earnings Per Share
As for profitability, COFACE has a trailing twelve months EPS of €1.9.
PE Ratio
COFACE has a trailing twelve months price to earnings ratio of 7.01. Meaning, the purchaser of the share is investing €7.01 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.81%.
Yearly Top and Bottom Value
COFACE’s stock is valued at €13.31 at 22:40 EST, under its 52-week high of €14.44 and way higher than its 52-week low of €9.23.
Moving Average
COFACE’s value is below its 50-day moving average of €13.59 and way higher than its 200-day moving average of €12.08.
More news about COFACE.
3. RANA GRUBER (RANA.OL)
7.41% Price Change
Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.
Oslo Børs Benchmark Index_GI ended the session with RANA GRUBER rising 7.41% to €55.10 on Friday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 0.29% to €1,215.57, after two sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr15.09.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 3.65. Meaning, the purchaser of the share is investing kr3.65 for every norwegian krone of annual earnings.
More news about RANA GRUBER.
4. SAS AB (SASNO.OL)
6.75% Price Change
SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Oslo Børs Benchmark Index_GI ended the session with SAS AB jumping 6.75% to €0.35 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.29% to €1,215.57, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, SAS AB has a trailing twelve months EPS of kr-1.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1151.97%.
Volume
Today’s last reported volume for SAS AB is 3711830 which is 17.56% below its average volume of 4502790.
Moving Average
SAS AB’s worth is under its 50-day moving average of kr0.36 and way under its 200-day moving average of kr0.48.
Yearly Top and Bottom Value
SAS AB’s stock is valued at kr0.35 at 22:40 EST, way under its 52-week high of kr0.95 and way above its 52-week low of kr0.20.
Volatility
SAS AB’s last week, last month’s, and last quarter’s current intraday variation average was 0.08%, 1.14%, and 4.46%.
SAS AB’s highest amplitude of average volatility was 1.14% (last week), 3.38% (last month), and 4.46% (last quarter).
More news about SAS AB.
5. CRCAM LANGUED CCI (CRLA.PA)
6.01% Price Change
Caisse Régionale de Crédit Agricole Mutuel du Languedoc Société Coopérative provides various banking products and services to individuals, professionals and associations, farmers, businesses, private banking customers, and public authorities and social housing community clients in France. It offers accounts and cards; savings products; loans; auto and 2 wheeler, personal, borrower, home, leisure and daily, professional premises, health, and activity insurance; and finance for the construction or renovation of buildings, purchases of agricultural equipment, and purchases of seeds and livestock. The company also provides corporate and investment banking, specialized financing, asset management, small and mid-cap merger and acquisition advice, and wealth management services; and treasury solutions, as well as engages in furniture leasing, and real estate and project financing activities. The company is based in Lattes, France. Caisse Régionale de Crédit Agricole Mutuel du Languedoc Société coopérative operates as a subsidiary of Crédit Agricole S.A.
CAC 40 ended the session with CRCAM LANGUED CCI jumping 6.01% to €52.50 on Friday while CAC 40 jumped 1.24% to €7,319.18.
Earnings Per Share
As for profitability, CRCAM LANGUED CCI has a trailing twelve months EPS of €11.02.
PE Ratio
CRCAM LANGUED CCI has a trailing twelve months price to earnings ratio of 4.76. Meaning, the purchaser of the share is investing €4.76 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.61%.
More news about CRCAM LANGUED CCI.
6. FAURECIA (EO.PA)
5.44% Price Change
Faurecia S.E., together with its subsidiaries, manufactures and sells automotive technology solutions in France, Germany, other European countries, the Americas, Asia, and internationally. It operates through Seating, Interiors, Clean Mobility, Electronics, Lighting, and Lifecycle Solutions segments. The Seating segment designs and manufactures vehicle seats, seating frames, covers, and comfort solutions, as well as adjustment mechanisms. The Interior segment designs, manufactures, and assembles instrument panels, cockpits, and door panels and modules, as well as center consoles, and sustainable materials. The Clean Mobility segment designs and manufactures exhaust system solutions for passenger and commercial vehicles; fuel cell electric vehicles; and aftertreatment solutions for commercial vehicles, as well as zero-emissions solutions. The Electronics segment designs and manufactures display technologies, driver assistance systems, and cockpit electronics, as well as sensors and actuators, lighting/body electronics, energy management, and HMI/displays. The Lighting segment designs and manufactures lighting technologies. The Lifecycle Solutions segment provides solutions extending the vehicle lifecycle, as well as workshop equipment and special original equipment. The company was incorporated in 1929 and is headquartered in Nanterre, France.
CAC 40 ended the session with FAURECIA jumping 5.44% to €20.75 on Friday, after three sequential sessions in a row of losses. CAC 40 jumped 1.24% to €7,319.18, after four consecutive sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, FAURECIA has a trailing twelve months EPS of €-2.2.
More news about FAURECIA.
7. POLIGHT (PLT.OL)
5.35% Price Change
poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. The company serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was incorporated in 2005 and is headquartered in Skoppum, Norway.
Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 5.35% to €11.42 on Friday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 0.29% to €1,215.57, after two sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.29%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 13.36M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
POLIGHT’s EBITDA is -60.85.
Yearly Top and Bottom Value
POLIGHT’s stock is valued at kr11.42 at 22:40 EST, way below its 52-week high of kr29.00 and higher than its 52-week low of kr10.58.
More news about POLIGHT.
8. ATOS (ATO.PA)
4.62% Price Change
Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.
CAC 40 ended the session with ATOS rising 4.62% to €13.80 on Friday while CAC 40 rose 1.24% to €7,319.18.
Earnings Per Share
As for profitability, ATOS has a trailing twelve months EPS of €-9.18.
Volume
Today’s last reported volume for ATOS is 982251 which is 16.84% below its average volume of 1181170.
More news about ATOS.
9. ARAMIS GROUP (ARAMI.PA)
3.67% Price Change
Aramis Group SAS engages in the online sale of used cars in Europe. The company operates Aramisauto, Cardoen, and Clicars brands in France, Belgium, and Spain, as well as CarSupermarket platform in the United Kingdom. Aramis Group SAS was founded in 2001 and is based in Arcueil, France.
CAC 40 ended the session with ARAMIS GROUP jumping 3.67% to €5.09 on Friday, following the last session’s upward trend. CAC 40 jumped 1.24% to €7,319.18, after four successive sessions in a row of losses, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, ARAMIS GROUP has a trailing twelve months EPS of €-0.69.
Volume
Today’s last reported volume for ARAMIS GROUP is 116051 which is 35.37% above its average volume of 85724.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARAMIS GROUP’s stock is considered to be oversold (<=20).
Volatility
ARAMIS GROUP’s last week, last month’s, and last quarter’s current intraday variation average was 1.69%, 0.96%, and 3.28%.
ARAMIS GROUP’s highest amplitude of average volatility was 5.27% (last week), 2.33% (last month), and 3.28% (last quarter).
More news about ARAMIS GROUP.
10. COHERIS (COH.PA)
3.45% Price Change
Coheris SA provides customer relationship management (CRM) and analytics solutions in France and internationally. The company offers data solutions, such as digital and speech intelligence, cyber security, data science, data operating system, data mining and machine learning, and business intelligence and analytics. It also provides CRM customer service, sales force, and marketing; and unified commerce, including digital in-store, order management system, e-merchandising and searchandsing, wen-to-store, store management, unified stocks, returns and refunds, and clienteling, as well as product recommendation, seller performance optimization, look book, and digital asset management services. In addition, the company offers merchandising, and e-merchandising and search software; marketing automation; and last mile logistics services. It serves bank and finance, mutual insurance, consumer goods and GICs, retail, agrifood, OTC and pharmacy, out-of-home consumption, industry, luxury premium, audience, and regalian sectors. The company is based in Suresnes, France. Coheris SA is as subsidiary of ChapsVision.
CAC 40 ended the session with COHERIS rising 3.45% to €4.20 on Friday, following the last session’s upward trend. CAC 40 rose 1.24% to €7,319.18, after four successive sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, COHERIS has a trailing twelve months EPS of €0.59.
PE Ratio
COHERIS has a trailing twelve months price to earnings ratio of 7.12. Meaning, the purchaser of the share is investing €7.12 for every euro of annual earnings.
Volume
Today’s last reported volume for COHERIS is 481 which is 88.59% below its average volume of 4218.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 13.8M for the twelve trailing months.
More news about COHERIS.
Losers Today
1. CASINO GUICHARD (CO.PA)
-10.06% Price Change
Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.
CAC 40 ended the session with CASINO GUICHARD sliding 10.06% to €6.08 on Friday while CAC 40 jumped 1.24% to €7,319.18.
Earnings Per Share
As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-3.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.53%.
More news about CASINO GUICHARD.
2. ABIONYX PHARMA (ABNX.PA)
-8.59% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA sliding 8.59% to €1.26 on Friday while CAC 40 jumped 1.24% to €7,319.18.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.7%.
More news about ABIONYX PHARMA.
3. BARBARA BUI (BUI.PA)
-8.16% Price Change
Barbara Bui SA engages in the manufacture, marketing, and sale of ready-to-wear clothing and accessories for women in France and internationally. The company offers jackets, tops and shirts, T-shirts, pants, dresses and skirts, coats, leather products, mesh, and tailored cloths; shoes; bags; and accessories, such as scarves, belts, card holder and key ring, wallets, and jewelries. It offers its products through wholesale distributors, as well as online and offline stores. The company was founded in 1983 and is based in Paris, France.
CAC 40 ended the session with BARBARA BUI dropping 8.16% to €9.00 on Friday, after two sequential sessions in a row of losses. CAC 40 rose 1.24% to €7,319.18, after four consecutive sessions in a row of losses, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, BARBARA BUI has a trailing twelve months EPS of €1.38.
PE Ratio
BARBARA BUI has a trailing twelve months price to earnings ratio of 6.52. Meaning, the purchaser of the share is investing €6.52 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.49%.
More news about BARBARA BUI.
4. GENSIGHT BIOLOGICS (SIGHT.PA)
-7.84% Price Change
GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.
CAC 40 ended the session with GENSIGHT BIOLOGICS sliding 7.84% to €0.75 on Friday while CAC 40 jumped 1.24% to €7,319.18.
Earnings Per Share
As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.59.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GENSIGHT BIOLOGICS’s stock is considered to be overbought (>=80).
More news about GENSIGHT BIOLOGICS.
5. BIGBEN INTERACTIVE (BIG.PA)
-4.91% Price Change
BigBen Interactive designs, produces, and distributes accessories for video game consoles, and smartphones and tablets in France and internationally. It offers audio products; technical support services; accessories, such as controllers, headsets, keyboards, mice, microphones, memory cards, protections, bags, etc. The company also develops, publishes, and distributes video games; and provides technical support services. BigBen Interactive was incorporated in 1981 and is headquartered in Lesquin, France.
CAC 40 ended the session with BIGBEN INTERACTIVE sliding 4.91% to €5.23 on Friday while CAC 40 rose 1.24% to €7,319.18.
Earnings Per Share
As for profitability, BIGBEN INTERACTIVE has a trailing twelve months EPS of €0.33.
PE Ratio
BIGBEN INTERACTIVE has a trailing twelve months price to earnings ratio of 15.85. Meaning, the purchaser of the share is investing €15.85 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.62%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 290.06M for the twelve trailing months.
More news about BIGBEN INTERACTIVE.
6. PCI BIOTECH HOLD (PCIB.OL)
-4.66% Price Change
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD falling 4.66% to €1.80 on Friday while Oslo Børs Benchmark Index_GI fell 0.29% to €1,215.57.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-1.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.97%.
Volatility
PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.21%, a negative 0.04%, and a positive 3.29%.
PCI BIOTECH HOLD’s highest amplitude of average volatility was 0.32% (last week), 4.47% (last month), and 3.29% (last quarter).
Volume
Today’s last reported volume for PCI BIOTECH HOLD is 23974 which is 69.66% below its average volume of 79037.
More news about PCI BIOTECH HOLD.
7. OCEANTEAM (OTS.OL)
-4.58% Price Change
Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.
Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM sliding 4.58% to €1.46 on Friday while Oslo Børs Benchmark Index_GI fell 0.29% to €1,215.57.
Earnings Per Share
As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.36.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.42%.
Yearly Top and Bottom Value
OCEANTEAM’s stock is valued at kr1.46 at 22:40 EST, way under its 52-week high of kr5.68 and way higher than its 52-week low of kr1.26.
Volatility
OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.67%, a positive 0.35%, and a positive 3.11%.
OCEANTEAM’s highest amplitude of average volatility was 4.29% (last week), 4.14% (last month), and 3.11% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OCEANTEAM’s stock is considered to be overbought (>=80).
More news about OCEANTEAM.
8. LERØY SEAFOOD GP (LSG.OL)
-4.49% Price Change
Lerøy Seafood Group ASA produces, processes, markets, sells, and distributes seafood products worldwide. It operates in three segments: Wildcatch; Farming; and Value-Added Processing, Sales and Distribution. The company offers smoked and gravad salmon, and trout products; farmed and wild catch whole fishes; fillets and portions; ready-to-eat and ready-to-cook products; fish blocks and cubes; breaded products; pre-fried fish burgers and patties; crustaceans and molluscs; seaweeds; and other products. Lerøy Seafood Group ASA markets its products primarily under the Norway Seafoods, Arctic Supreme, Fjord trout, Aurora Salmon, Fossen, Sea Eagle, Lerøy, and M?r brands to shops, restaurants, canteens, and hotels. The company was founded in 1899 and is headquartered in Bergen, Norway. Lerøy Seafood Group ASA is a subsidiary of Austevoll Seafood ASA.
Oslo Børs Benchmark Index_GI ended the session with LERØY SEAFOOD GP falling 4.49% to €49.38 on Friday while Oslo Børs Benchmark Index_GI fell 0.29% to €1,215.57.
Earnings Per Share
As for profitability, LERØY SEAFOOD GP has a trailing twelve months EPS of kr5.17.
PE Ratio
LERØY SEAFOOD GP has a trailing twelve months price to earnings ratio of 9.55. Meaning, the purchaser of the share is investing kr9.55 for every norwegian krone of annual earnings.
More news about LERØY SEAFOOD GP.
9. GRIEG SEAFOOD (GSF.OL)
-4.24% Price Change
Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the production and sale of Atlantic salmon. The company was founded in 1884 and is headquartered in Bergen, Norway. Grieg Seafood ASA operates as a subsidiary of Grieg Aqua AS.
Oslo Børs Benchmark Index_GI ended the session with GRIEG SEAFOOD sliding 4.24% to €85.90 on Friday while Oslo Børs Benchmark Index_GI dropped 0.29% to €1,215.57.
Earnings Per Share
As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr7.29.
PE Ratio
GRIEG SEAFOOD has a trailing twelve months price to earnings ratio of 11.78. Meaning, the purchaser of the share is investing kr11.78 for every norwegian krone of annual earnings.
Moving Average
GRIEG SEAFOOD’s value is above its 50-day moving average of kr80.14 and above its 200-day moving average of kr84.59.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 9, 2023, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 5.02%.
Volatility
GRIEG SEAFOOD’s last week, last month’s, and last quarter’s current intraday variation average was 0.57%, 0.07%, and 2.01%.
GRIEG SEAFOOD’s highest amplitude of average volatility was 4.63% (last week), 2.73% (last month), and 2.01% (last quarter).
More news about GRIEG SEAFOOD.
10. SALMAR (SALM.OL)
-4.07% Price Change
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming, Sales & Industry, Icelandic Salmon, and SalMar Aker Ocean segments. It is involved in the broodstock, lumpfish, and smolt production activities; and marine-phase farming, harvesting, processing, and selling farmed salmon. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Oslo Børs Benchmark Index_GI ended the session with SALMAR dropping 4.07% to €496.90 on Friday while Oslo Børs Benchmark Index_GI fell 0.29% to €1,215.57.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr29.88.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 16.63. Meaning, the purchaser of the share is investing kr16.63 for every norwegian krone of annual earnings.
More news about SALMAR.
Stay up to date with our winners and losers daily report
